Characterization of human ovarian carcinomas in a SCID mouse model

Gynecologic Oncology

Volumn 72, Issue 2, 1999, Pages 161-170

  Xu, Yan ^a   Silver, David F ^a   Yang, Ning Ping ^a   Oflazoglu, Ezogelin ^a   Hempling, Ronald E ^a   Piver, M Steven ^a   Repasky, Elizabeth A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CANCER GRAFT; CANCER GROWTH; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; METASTASIS; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0032933206     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5238     Document Type: Article

References (30)

1. Cancer Facts and Figures 1995. Atlanta, GA, American Cancer Society, 1995
2. Markman M: Current status and future directions of platinum/paclitaxelbased chemotherapy of ovarian cancer. Semin Oncol 24:S11-24-27, 1997
3. Davy M, Mossige J, Johannesson J: Heterologous growth of human ovarian cancer. A new in vivo testing system. Acta Obstet Gynecol Scand 56:55-59, 1977
4. Kullander S, Rausing A, Trope C: Human ovarian tumor heterotransplanted to nude mice. Acta Obstet Gynecol Scand 57:149-159, 1978
5. Tactle R, Howell SB, Giuliani F, Koziol J, Koessler A: Comparison of the activity of doxorubicin analogues using colony forming assays and human xenografts. Cancer 50:1455-1461, 1982
6. Sawada M, Terada N, Wada A, Mori Y, Yamasaki M, Saga T, Endo K: Estrogen- and androgen-responsive growth of human ovarian carcinoma heterotransplanted into nude mice. Int J Cancer 45:359-363, 1990
7. Fogh JM, Fogh JM, Orfeo T: One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221-226, 1977
8. Jones AC, Wilson PA, Steel GG: Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin, and cis-diammline-1,1-cyclobutane dicarboxylate platinum ii (CBCDA,JM8). Cancer Chemother Pharmacol 13:109-113, 1984
9. Morrow CP: Malignant and Borderline Tumors of the Ovary: Clinical Features and Management, in Coppelson M (ed): Gynaecologic Oncology, Edinburgh, Churchill Livingstone, 1981, p 667
10. Boven E, van der Vijgh WJF, Nauta MM, Schluper HMM, Pinedo HM: Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts. Cancer Res 45:86-90, 1985
11. Buick RN, Pullano R, Trent JM: Comparative properties of five ovarian adenocarcinoma cell lines. Cancer Res 45:3668-3676, 1985
12. Hill BT, Whelan RDH, Gibby EM, Sheer D, Hosking LK, Shellard SA, Rupnniak HT: Establishment and characterization of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies. Int J Cancer 39:219-225, 1987
13. Hamilton TC, Young RC, Louie KG, Behrens BC, McKoy WM, Grotzinger KR, Ozols RF: Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. Cancer Res 44:5286-5290, 1984
14. Wahl R, Piko C: Intraperitoneal (IP) delivery of radiolabelled monoclonal antibody to IP-induced xenografts of ovarian cancer. Proc Am Assoc Cancer Res 26:298, 1985
15. Baumal R, Law J, Buick RN, Kahn H, Yeger H, Sheldon K, Colgan T, Marks A: Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line. Cancer Res 46:3994-4000, 1995
16. Walker W, Gallagher G: The development of a novel immunotherapy model of human ovarian cancer in human PBL-severe combined immunodeficient (SCID) mice. Clin Exp Immunol 101:494-501, 1995
17. Ward BG, Wallace K, Shepherd JH, Balkwill FR: Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res 47:2662-2667, 1987
18. Massazza G, Tomasoni A, Lucchini V, Allavena P, Erba E, Colombo N, Mantovani A, Incalci MD, Mangioni C, Giavazzi R: Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy. Int J Cancer 44:494-500, 1989
19. Fu X, Hoffman RM: Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res 13(2):283-286, 1993
20. Schumacher U, Adam E, Horny HP, Dietl J: Transplantation of a human ovarian cystadenocarcinoma into severe combined immunodeficient (SCID) mice-formation of metastases without significant alteration of the tumor cell phenotype. Int J Exp Pathol 77(5):219-227, 1996
21. Schumacher U, Adam E, Dietl J, Horny HP: Immunophenotype of human ovarian malignancies (cystadenocarcinomata and mixed mullerian tumor) established in SCID mice. Exp Mol Pathol 64(2):103-113, 1997
22. William SS, Alosco TR, Croy BA, Bankert RB: The study of human neoplastic disease in severe combined immunodeficient mice. Lab Animal Sei 43(2):139-147, 1993
23. Sakakibara T, Xu Y, Bumpers HL, Chen FA, Bankert RB, Arredondo MA, Edge SB, Repasky EA: Growth and metastasis of surgical specimens of human breast carcinoma in SCID mice. Cancer J Sci Am 2:291-300, 1996
24. Paine GD, Tayor CW, Lopez MH, Johnson CS, Capizzi RL: Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary results. Semin Oncol 23(4 Suppl 8):35-39, 1996
25. Rosenfeld ME, Wang M, Siegal GP, Alvarez RD, Mikheeva G, Krasnykh V, Curiel DT: Adenoviral-mediated delivery of herpes simplex virus thymidine results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma. J Mol Med 74(8):455-462, 1996
26. Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I: A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16. Cancer Res 53(1):94-100, 1993
27. Garofalo A, Chirivi RGS, Scanziani E, Mayo JG, Vecchi A, Giavazzi R: Comparative study on the metastatic behavior of human tumors in Nude, Beige/Nude/Xid and Severe Combined Immunodeficient Mice. Invasion Metast 13:82-91, 1993
28. Werenius HM: Identification and Separation of Mouse and Human Components of Heterotransplanted Human Tumors. in: Sparrow S (ed): Immunodeficient Animals in Cancer Research, MRC, Laboratory Animals Center Symposium II. London, Macmillan, 1980, pp 207-220
29. Rygaard K: A Rapid Method for Identification of Murine Cells in Human Malignant Tumors Grown in Nude Mice, in Rygaad, Brunner, Gram, Spang-Thomsen (eds): Immune-Deficient Animals in Biomedical Research. Copenhagen, 5th International Workshop on Immune-Deficient Animals, 1985, pp 268-272
30. Williams SS, Chen F-A, Kida H, Yokota S, Miya K, Kato M, Barcos MP, Wang H, Alosco T, Umemoto T, Croy BA, Repasky EA, Bankert RB: Engraftment of human tumor-infiltrating lymphocytes and the production of anti-tumor antibodies in SCID mice. J Immunol 156: 1908-1915, 1996